NTRK1 and cancer: Ntn1 (Netrin-1) controls Par complex localisation during axon guidance29, and Spry2 (Sprouty2) is a modulator of tyrosine receptor kinase signalling that was previously shown to repress the polarised epithelial phenotype of cancer cells30.